A mouse model of Graves' orbitopathy (GO) induced by genetic immunization of human TSH receptor (TSHR) A-subunit encoding plasmid has recently been established. The orbital pathology was characterized by adipogenesis, myopathy and fibrosis. Human orbital fibroblasts (OFs) express TSHR and IGF-1 receptor (IGF-1R) and are considered to be pathogenic in GO. We established conditions for growing ex vivo cultures of mouse OFs (mOFs) from orbital tissue of animals undergoing GO and controls. Early passage mOFs showed characteristic fibroblast morphology and expressed mesenchymal stem cell markers including a strong expression of CD90.2 and CD40, whereas display of CD73 and all other leucocyte markers was uniformly absent. Importantly, OFs derived from GO mice expressed elevated levels of TSHR and IGF-1R and showed enhanced adipogensis compared with controls. Activation of TSHR in mOFs from GO animals with TSH, monoclonal thyroid-stimulating antibody M22, or stimulation of IGF-1R with IGF-1-induced hyaluronan secretion to significantly elevated levels compared with control animals. Hyaluronan synthase 2 was more abundant in OFs derived from GO mice. In conclusion, mOFs established from GO model recapitulate the pathogenicity of human OFs from GO patients by their increased propensity for adipogenesis and hyaluronan production leading to disease activity. To our knowledge, this is the first report to show mOFs from the preclinical GO model have pathogenic properties that will aid in understanding the molecular and genetic changes during progression to adipogenesis and hyaluronan deposition to provide new insights into GO pathogenesis. (Endocrinology 157: 3771-3778, 2016)
G
raves' disease is an antibody mediated autoimmune condition of the thyroid gland, where stimulating antibodies to the TSH receptor (TSHR) activate the gland resulting in hyperthyroidism. One complication of Graves' disease is Graves' orbitopathy (GO), arising from inflammation of the orbital connective tissue in the eye, characterized by adipogenesis and deposition of glycosaminoglycan (1) . The orbital fibroblasts (OFs) are the sentinel pathogenic cells in GO and respond to TSHR antibodies, inflammatory T cells, and cytokines in the orbit by undergoing differentiation to adipocytes and hyaluronan production (2) . The ability to grow ex vivo human OFs as monolayer cultures from surgical specimens obtained from corrective surgery of GO patients have been instrumental in studying their interaction with the immune system in disease pathogenesis. OFs express functional molecules such as TSHR, IGF-1 receptor (IGF-1R), and CD40 and respond to their activation by differentiation into adipocytes together with secretion of inflammatory cytokines and production of hyaluronan (2, 3) . Furthermore, 2 phe-notypic subpopulations of human OF distinguished by stable expression of CD90 (Thy1) has been identified, with CD90 negative population of OF responsible for adipogenesis and CD90-positive cells with myogenic differentiation ability. Moreover, the CD90-positive fibroblasts appear to be heterogeneously distributed in orbital connective tissue in different disease subtypes, implicating these cells to be pivotal in pathogenesis of GO (4 -6). In (7, 8) .
Recently, we developed an induced experimental model of GO by genetic immunization of BALB/c mice with plasmid encoding the A subunit of human TSHR (termed hTSHR A-subunit) (9, 10) . Although genetic immunization with hTSHR A-subunit plasmid is effective in inducing experimental GO, similar immunization with human IGF-1R ␣-subunit coding region plasmid does not lead to any manifestation of disease, providing compelling evidence on the role of TSHR as a primary antigen in GO pathogenesis (9, 11) . All GO mice were serum positive for TSHR antibodies and some of the GO mice showed elevated levels of anti-IGF-1R antibodies (10) . The orbital pathology in GO mice was reminiscent of human GO showing adipogensis and myopathy (10) . Moreover, antigen specific T cells from GO mice show robust responses to TSHR protein antigen by secretion of a cocktail of proinflammatory cytokines, which in the orbital tissue may lead to onset of inflammation and GO (10) . In GO patients, OFs are considered to be pathogenic by mediating inflammatory and remodeling processes in the orbital tissue (2) . In this study, our aim was to identify the pathologic cell type in the mouse orbital tissue from animals undergoing experimental GO and to determine whether they showed similar properties to those derived from human GO patients. Here, we demonstrate the ex vivo cultivation and characterization of OFs from GO mice and controls and show their inherent ability for adipocyte differentiation and hyaluronan production when activated by a variety of ligands, including TSH and IGF-1. Our study suggests mouse OFs (mOFs) as a pathogenic cell type responsible for tissue expansion in the orbital region of GO mice. The availability of ex vivo mOF cultures from GO mice at different stages of disease will provide novel genetic and molecular signatures associated with GO pathogenesis to provide new intervention targets for the disease.
Materials and Methods

Cell culture
All the orbital cultures were established from female BALB/c mice immunized with hTSHR A-subunit plasmid (GO mice, n ϭ 10) or control ␤-galactosidase plasmid (Ctrl mice, n ϭ 8) and killed 9 weeks after the last immunization, derived from center 2 (University of Duisburg-Essen) described in our recent study (10) . After killing, for each mouse one orbit was excised in sterile hood under aseptic conditions, and the bulbar tissue was dissected by careful removal of the harderian gland, and the oblique/ press.endocrine.org/journal/endotear muscles and transferred directly into 35-mm culture dish containing standard medium: DMEM (Invitrogen) supplemented with 10% fetal calf serum, 10mM HEPES (pH 7.4), 2mM L-glutamine, 1mM sodium pyruvate, 100mM nonessential amino acids, 100-U/mL penicillin, and 100-g/mL streptomycin. The other orbit was processed for histology as described earlier (10, 12) . The mouse OFs were obtained from the bulbar tissue by out-grow protocol as described earlier for human OFs (8, 13, 14) . After 3-4 weeks, the orbital tissue and nonadherent cells were removed by washing with PBS. Once cells grew in adherent monolayers, they were transferred to a 75-mL flask, serially passaged, and maintained in medium described above. All experiments were performed with orbital cells between passages 2 and 8 after culture initiation. 
Flow cytometry
Western blot analysis
Cells were grown in 6-well dishes at 5 ϫ 10 5 cells overnight, lysed in 50-L extraction buffer (300mM NaCl, 10nM Tris/HCl [pH7.9], 1mM EDTA, 0.1% Nonidet P-40, and protease inhibitors [Roche Applied Science]) for 20 minutes on ice. After centrifugation at 3600g at 4°C for 5 minutes to remove cellular debris, supernatants were subjected to Western blotting (50-g protein per lane) using antibodies for detection of TSHR, IGF-1R, CD40, hyaluronan synthase 2 (HAS2), and GAPDH as described in Table 1 . Western blot analysis was carried out as described earlier (15) . Quantification of Western blotting signals was conducted with ImageJ software.
Differentiation assays and microscopy
Cells were seeded at a density of 1 ϫ 10 5 cells per well on coverslips in 24-well dishes and grown in standard culture medium until reaching 90% confluence. For myogenic differentiation, cells were cultured on coverslips and seeded at a density of 1 ϫ 10 4 in 96-well plates. Cells were incubated with or without 500-ng/mL TGF-␤ (Peprotech) for 48 hours and immunostained for ␣-smooth muscle actin (␣-SMA) as described before (8) . Im- Western blotting signals from mOFs derived from individual Ctrl mice (n ϭ 8) or GO mice (n ϭ 10) were quantified by densitometry using ImageJ software. TSHR, IGF-1R, and CD40 signals were normalized to GAPDH signals and are shown as normalized protein expression. A representative experiment of at least 3 independent experiments is shown. OFs derived from GO mice expressed elevated levels TSHR and IGF-1R protein compared with Ctrl mice derived OFs. CD40 was expressed to high levels by mOFs derived from GO mice.
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Görtz et al Mouse OFs in GO Endocrinology, October 2016, 157(10):3771-3778 ages were generated using an Olympus BX51 microscope. Fluorescence intensity of stained cells was quantified with a fluorescence plate reader (FLUOstar Omega; BMG LABTECH) using an excitation at 485 nm and an emission at 520 nm. Adipogenic differentiation was induced with mouse adipogenic stimulatory supplement diluted 1:5 in mouse Mesencult MSC Basal medium (both Stemcell Technologies). The medium does not contain antibiotics and is specifically formulated for the in vitro differentiation of mouse MSCs into cells of the adipogenic lineage (16) . The medium was exchanged every 3-4 days during the 21-day differentiation period. To analyze the accumulation of lipid droplets in the cytoplasm after differentiation, cells were fixed with 10% paraformaldehyde, rinsed with 60% isopropanol solution, and stained with Oil Red O solution (Sigma). Cells were counterstained with Mayers hematoxylin solution (Sigma).
Images were generated using an Olympus BX51 microscope. Quantification of Oil Red O staining was conducted in 4 field views of each of individual GO-or Ctrl-derived mOF at ϫ40 and analyzed using ImageJ software. The microscopic images were segmented by thresholding to detect and to quantify the red stained particles from the background noise.
Hyaluronan ELISA
Cells were seeded at a density of 1 ϫ 10 4 cells per well on 96-well dishes and grown in standard culture medium. After 1 day, the medium was exchanged with low serum medium (1%). The cells were pretreated for 1h hour by 37°C with hyaluronidase (1 U/mL; Sigma) and stimulated with TSHR mAb M22 (0.1 g/mL), bovine TSH (100 mU/mL; Sigma), IGF-1 (0.1 g/mL; R&D Systems), or control IgG (0.1 g/mL) for 5 days. Hyaluronan levels in the supernatants were measured using an ELISA kit (R&D Systems) according to the manufacturer's instructions. Samples were diluted 1:50 before analysis. Viability/density of cells was measured with (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromid) assay as described earlier (14) .
Statistical analysis
Statistical analyses were performed with 2-tailed Student's t tests with a confidence level greater than 95%. Data are presented as arithmetic mean Ϯ SEM. Statistical significance was set at the level of P Յ .05 with * P Ͻ .05 and ** P Ͻ .01.
Results and Discussion
For the establishment of mouse OF model, all GO and Ctrl mice were derived from our recently described study, where orbital tissue from one eye was used for histological analysis and the orbital tissue of the second eye was excised under aseptic conditions for the cultures (10) . Histological analysis revealed that the excised mouse orbital tissue contained the optic nerve with connective/fat tissue, extraocular muscles, and harderian gland ( Figure  1A) . For in vitro studies of OFs from GO patients, the tissue has frequently been obtained from either fat/connective tissue or extraorbital muscles (13, 17) . To excise the orbital tissues from mice orbits, the harderian gland and the oblique/tear muscles was carefully removed from the mice orbits. The remaining bulbar tissue including the press.endocrine.org/journal/endooptic nerve, connective fat/tissue, and extraocular muscles (rectus and retractor bulbi muscles) was placed in a cell culture dish (Figure 1 , B and C). At 1 week of initial culture, fibroblast-like cells migrated out from the orbital tissue and adhere to the dish ( Figure 1D ). A confluent monolayer was obtained after 3-4 weeks (Figure 1 , E and G), and cells were passaged and cultivated like human OFs up to maximum 6 -8 passages. Similarly, mouse orbital cells from Ctrl mice grow equally well as those derived from GO mice with highly similar fibroblast-like appearance and proliferation ( Figure 1, F and H) . Having established cell culture of mOFs, we characterized the cells by phenotyping several surface marker and receptors ( Figure  2 ) as well as by analyzing their myocyte and adipocyte differentiation ability (Figure 3) . Furthermore, we measured hyaluronan secretion of the cells in response to TSHR and IGF-1R stimulation ( Figure 4) . The immune phenotype of GO-and Ctrl animals-derived mOFs were highly similar (Figure 2A ). They were positive for MSC marker CD29, CD44, CD90.2, CD105, CD106, Sca-1, and negative for leukocyte marker CD11.b and CD45, which indicates their mesenchymal cell immune phenotype akin both to mouse bone marrow stem cells or embryonic fibroblasts (18, 19) and human OFs (7, 8, 14) . However, the mOFs were negative for MSC marker CD73, indicating that the cells were similar but not identical to OFs or orbital MSCs derived from GO patients orbital fat tissue (8, 14) . CD73 functions as an ecto-enzyme to produce adenosine that exerts immune suppressive properties by negatively regulating Th1 immune responses. Consequently, CD73 inhibition or deficiency leads to increased susceptibility to autoimmune conditions like arthritis in mice (20) . However, the role of CD73 in GO still awaits further investigation. Human OFs can be separated into 2 populations based on expression of CD90 (Thy1), and different proportions of CD90 positive/negative cells have been observed in GO patients dependent on orbital localization with CD90-positive cells more abundant in extraocular muscles (21) . In our study, the mOFs express high levels of mouse strain specific Thy1 allele CD90.2. Interestingly, mOF derived from GO mice showed a statistically significant increase in low expressing cells compared with Ctrl mOF (Figure 2A ). However, we do not find subdivision of 2 distinct populations based on Thy1 expression as we and others have observed in OF derived from GO patients (4, 8) . Because the main body of mouse orbital tissue was extraocular muscle, high CD90.2 expression of derived mOFs most likely reflects rather their muscle than fat tissue origin. This notion is confirmed by the finding that mOFs expressed basically high amounts of ␣-SMA that was not further increased in response to TGF-␤ stimulation ( Figure 3A ), indicating constitutive myogenic differentiation of the cells (5, 8, 22) .
The main target antigens involved in GO pathology are TSHR and IGF-1R, which are expressed to highest levels in orbital tissues of GO patients and derived OFs (23) (24) (25) . Previously, we have shown high expression of TSHR in the retroorbital tissue in several mice strains (12, 26) and concordantly the OFs derived from both GO and Ctrl mice expressed TSHR and also IGF-1R (Figure 2, A and B) . However, unlike of the mesenchymal marker these antigens were expressed to higher levels on OFs derived from GO mice compared with Ctrl mice derived fibroblasts ( Figure 2, A and B) . Further significant differences between GO-and Ctrl-derived mOFs were obtained when adipogenesis and hyaluronan production of the cells was investigated (Figures 3 and 4) . Mouse OFs derived from GO mice readily differentiated into adipocytes when in- cubated with mouse adipocyte differentiation medium, whereas Ctrl mice-derived mOFs remained less responsive ( Figure 3B ). The data indicate that the mOFs population derived from GO mice contained substantially preadipocytes capable of differentiating into adipocytes just like OF population derived from GO patients (8, 27) . However, it remains to be investigated whether the CD90.2 low expressing cells were responsible for elevated adipocyte differentiation of mOF derived from GO mice. It was shown that either TSHR or IGF-1R activation of human orbital preadipocytes/fibroblasts does increase hyaluronan production (28 -31) . Likewise, GO-derived mOFs secreted elevated levels hyaluronan compared with Ctrl-derived mOFs, and statistically significant differences occurred after stimulation of TSHRs and/or IGF-1Rs (Figure 4) . Hyaluronan production of GO-derived mOFs was significantly induced in response to TSH and/or IGF-1 or stimulating TSHR mAb M22 when compared with hyaluronan production of Ctrl-derived mOFs ( Figure 4A ). Three HASs (HAS1-HAS3) control hyaluronan abundance, but HAS2 is considered to represent the major contributor of hyaluronan overproduction in the human orbit (29, 32) . We found high constitutive HAS2 protein expression in OFs derived from GO mice ( Figure 4B ). Thus, overexpression of TSHR, IGF-1R, and HAS2 most likely contributed to the stimulatory effect of TSH and/or IGF-1 or M22 on hyaluronan production of mOF in GO-derived mice. Furthermore, human OFs are prime targets of T-cell response in GO, and it has been shown that T cells also stimulate adipogenic differentiation and hyaluronan production (33, 34) . Just like human OFs, the OFs derived from GO mice expressed CD40 to high levels ( Figure 2B) , and CD40-CD154 ligation with T cells could be another potential pathway by which OFs were activated in GO mice. Finally, in this study, we have investigated mOFs populations derived from the orbital tissue of mice undergoing experimental GO or Ctrl mice immunized with ␤-galactosidase plasmid. However, studies in human GO patients using fibroblast populations from other anatomical sites such as dermal fibroblasts from normal individuals have provided compelling evidence that they are distinct in their hyperresponsive phenotype from the OFs derived from the orbital region (28) . In this context, human dermal fibroblasts from GO patients or in the GO model, mouse fibroblast derived from other anatomical sites remain to be evaluated.
To our knowledge, this is the first report on ex vivo cultures of mouse OFs. Our data provide evidence that mOFs are substantially affected in response to systemic hTSHR A-subunit immunization and recapitulate the main features of human OF derived from GO patients and are therefore to be considered as pathogenic cell type responsible for tissue expansion in the orbit of GO mice. Whether TSHR and IGF-1R antibodies present in the GO mice (10) are the main cause or TSHR primed T cells and/or inflammatory cytokines present in the GO mice (10) were the main activating factors is open question and subject of further investigations. The study opens the way to investigate phenotypic and molecular changes in stimulated OF cultures from immune mice at different stages of disease to evaluate their progression to disease pathogenesis, which are not possible with human OFs.
